Blackstone / GSO Long-Short Credit Income Fund (BGX) Is At $16.81 Formed Wedge; WUXI BIOLOGICS CAYMAN ORDINARY SHARE (WXIBF) Shorts Lowered By 6.37%

Blackstone / GSO Long-Short Credit Income Fund (BGX) formed wedge up with $18.32 target or 9.00% above today’s $16.81 share price. Blackstone / GSO Long-Short Credit Income Fund (BGX) has $ valuation. The stock increased 0.30% or $0.05 during the last trading session, reaching $16.81. About 34,298 shares traded or Infinity% up from the average. Blackstone / GSO Long-Short Credit Income Fund (NYSE:BGX) has risen 1.16% since June 24, 2017 and is uptrending. It has underperformed by 11.41% the S&P500.

WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF) had a decrease of 6.37% in short interest. WXIBF’s SI was 1.17 million shares in June as released by FINRA. Its down 6.37% from 1.25 million shares previously. With 20,100 avg volume, 58 days are for WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF)’s short sellers to cover WXIBF’s short positions. It closed at $12 lastly. It is down 0.00% since June 24, 2017 and is . It has underperformed by 12.57% the S&P500.

WuXi Biologics Inc., an investment holding company, provides integrated biologics outsourcing services worldwide. The company has market cap of $13.71 billion. The firm offers services for the discovery, development, and manufacture of biologics, such as monoclonal antibodies, recombinant therapeutic proteins, fusion proteins, vaccines, blood and blood components, allergenics, somatic cells, gene therapy, and tissues. It has a 352.94 P/E ratio. It serves pharmaceutical and biotechnology companies.